Treatment of Influenza in Routine Clinical Practice
NCT02983019 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18946
Last updated 2017-02-17
Summary
This study evaluates the statistics of influenza and acute respiratory viral infections (ARVI) management in outpatient sites in Russia, Armenia, Moldova and Georgia (epidemiology: disease severity and bacterial exacerbations; patients demography; treatment duration and timelines; safety; quality of treatment) in routine clinical practice with focus on drug therapy and usage of interferons' inducers.
Conditions
- Influenza
- Acute Upper Respiratory Infection
Interventions
- DRUG
-
Kagocel
Investigators could prescribe other drugs in frame of routine clinical practice
Sponsors & Collaborators
-
Nearmedic Plus LLC
lead INDUSTRY
Principal Investigators
-
Ivan Sitnikov, Professor · Yaroslavl State Medical University
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-12-31
- Primary Completion
- 2015-12-31
- Completion
- 2016-09-30
Countries
- Armenia
- Georgia
- Moldova
- Russia
Study Locations
More Related Trials
-
Rapid Evaluation of Seasonal Influenza Vaccine
NCT00966342 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Double-blind Randomized Placebo-controlled Study Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac
NCT04034290 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Influenza Vaccine Evaluation of Immune Response
NCT03598439 ·Status: COMPLETED ·Phase: PHASE4
-
A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD
NCT03734237 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
D2560C00015 FluMist Annual Safety Study 2018
NCT03564444 ·Status: COMPLETED ·Phase: PHASE4
-
Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)
NCT03028974 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Study to Assess the Safety of a New Influenza Vaccine
NCT01104493 ·Status: COMPLETED ·Phase: PHASE4
-
Respiratory Virus Outpatient Study (FLU 002 Plus)
NCT01056354 ·Status: COMPLETED
-
Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine
NCT04025580 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults
NCT01389479 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People
NCT06683352 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Reactogenicity, Safety and Immunogenicity of an Universal Influenza Vaccine Uniflu
NCT03789539 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009, When Administered to Non-Elderly Adult and Elderly Subjects
NCT00748150 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety of FluMist in Healthy Children and Healthy Adults
NCT00113880 ·Status: COMPLETED
-
A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults
NCT00920374 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity & Safety Study of Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years
NCT00929331 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment
NCT00138385 ·Status: COMPLETED ·Phase: PHASE4
-
GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE
NCT06620185 ·Status: RECRUITING ·Phase: NA
-
The Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac
NCT03651544 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season
NCT03158038 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity Study of Fluval AB-Like Flu Vaccines With 3.5, 6, 9 or 15 μg HA in Adult and Elderly People
NCT01408290 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine
NCT02222870 ·Status: COMPLETED ·Phase: PHASE4
-
Self-Administered Nasal Influenza Feasibility Study
NCT01933048 ·Status: COMPLETED ·Phase: PHASE4
-
Influenza Immunity in Children
NCT02559505 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season
NCT02473510 ·Status: COMPLETED ·Phase: PHASE4